In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.

Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.

Magazine

Publication of first clinical evidence for EHO-85 hydrogel

The first clinical evidence related to an hydrogel based on Olea europaea leaf extract (EHO‐85) indicated for the healing of wounds of full and partial thickness has been published in the Journal of Clinical Medicine.

Read more
Impact of Covid-19 on UTI and antibiotic stewardship (T. Cai et al. on Uro 2022)

Several recent studies showed that, despite the overall percentage of bacterial co-infection among COVID-19 patients was low, the use of antibiotic was high. This motivated a team of urologists led by Prof. Tommaso Cai, from the Department of Urology, Santa Chiara Regional Hospital, to discuss the role of managing urinary tract infections during the COVID-19 pandemic.

Read more
First publication for OLE hydrogel

We are happy to announce the publication in Pharmaceutics of the first paper related to our hydrogel based on Olea europaea leaf extract (OELE) indicated for the healing of wounds of full and partial thickness.
The publication is based on a study that has been designed and carried out by several authors who come from different areas of basic research and therapeutic management of skin lesions of any depth.

Read more